Quantification of omeprazole degradation by enteric coating polymers: An UV-VIS spectroscopy study

Pharmazie

Volumn 60, Issue 2, 2005, Pages 126-130

  Riedel, A ^a   Leopold, Claudia S ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CATION; EUDRAGIT RS; MONOMER; OMEPRAZOLE; POLYMER; PROTON PUMP INHIBITOR;

ARTICLE; CALCULATION; COLOR; DATA ANALYSIS; DEGRADATION KINETICS; DISPERSION; DRUG ABSORPTION; DRUG COATING; DRUG DEGRADATION; DRUG DETERMINATION; DRUG STORAGE; ENTERIC COATED TABLET; EVALUATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; POLYMERIZATION; STRUCTURE ANALYSIS; ULTRAVIOLET SPECTROSCOPY;

ACETIC ACID; ACRYLIC RESINS; ANTI-ULCER AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLOR; DRUG COMPOUNDING; DRUG STABILITY; ETHANOL; EXCIPIENTS; OMEPRAZOLE; POLYMERS; SOLUTIONS; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS, ENTERIC-COATED;

EID: 14244270194     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Amantea MA, Narang PK (1988) Improved procedure for quantitation of omeprazole and its metabolites using reversed-phase high-performance liquid chromatography. J Chramatogr Biomed Appl 426: 216-222.
2. Andersson T et al. (1993) High-Performance Liquid-Chromatographic assay for human liver microsomal omeprazole metabolism. J Chromatogr Biomed Appl 619: 291-297.
3. Arias-Blanco MJ et al. (1996) Preliminary study of different omeprazole/gamma-CD co-ground systems. Int J Pharm 143: 113-118.
4. Arvidsson T et al. (1991) Peak distortion in the column liquid-chromatographic determination of omeprazole dissolved in borax buffer. J Chromatogr 586: 271-276.
5. Bozdag S et al. (1999) Formulation and stability evaluation of enteric-coated omeprazole formulations. STP Pharma Sci 9: 321-327.
6. Brändström A et al. (1989) Chemical reactions of omeprazole and omeprazole analogues. I. A survey of the chemical transformation of omeprazole and its analogues. Acta Chem Scand 43: 536-548.
7. Castro D et al. (1999) Comparison of derivative spectrophotometric and liquid chromatograpic methods for the determination of omeprazole in aqueous solutions during stability studies. J Pharm Biomed Anal 21: 291-298.
8. Clissold SP, Campoli-Richards DM (1986) Omeprazole - A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 32: 15-47.
9. Davidson AG, McCallum A (1996) A survey of the stability of omeprazole products from 13 countries. Drug Dev Ind Pharm 22: 1173-1185.
10. Eger K et al. (1999) Benzimidazol-Derivate. In: (ed.) Arzneistoffanalyse, 4. Auflage, Stuttgart, p. 537-541.
11. Ekpe A, Jacobsen T (1999) Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography. Drug Dev Ind Pharm 25: 1057-1065.
12. El-Kousy NM, Bebawy LI (1999) Stability-indicating methods for determining omeprazole and octylonium bromide in the presence of their degradation products. J AOAC Int 82: 599-606.
13. Farinha A et al. (2000) Dissolution of omeprazole from delayed-release solid oral dosage forms. Drug Dev Ind Pharm 26: 785-790.
14. Hamdan II (2001) In vitro study of the interaction between omeprazole and the metal ions Zn(II), Cu(II), and Co(II). Pharmazie 56: 877-881.
15. Kobayashi K et al. (1992) Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed phase high performance liquid chromatography with an alkaline-resistant polymer coated C18 column. J Chromatogr Biomed Appl 117: 299-305.
16. Lagerström P-O, Persson B-A (1984) Determination of omeprazole and metabolites in plasma and urine by liquid chromatography. J Chromatogr Biomed Appl 309: 347-356.
17. Lövgren KI et al. (1987) EP 0 2479 83 B1
18. Mathew M et al. (1995) Stability of omeprazole solutions at various pH values as determined by High-Performance Liquid Chromatography. Drug Dev Ind Pharm 21: 965-971.
19. Persson B-A et al. (1985) Determination of omeprazole and metabolites in plasma and urine. Scand J Gastroenterol 20: 71-77.
20. Ph. Eur. (2002) edition 4.0.
21. Pilbrant A (1985) Development of an oral formulation of omeprazole. Scand J Gastroenterol 20: 113-119.
22. Quercia RA et al. (1997) Stability of omeprazole in an extemporaneously prepared oral liquid. Am J Health Syst Pharm 54: 1833-1836.
23. Riedel A, Leopold CS (2004) Degradation of omeprazole induced by enteric polymer solutions and aqueous dispersions: HPLC investigations. Drug Dev Ind Pharm, submitted.
24. Salama F et al. (2003) Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates. J Pharm Biomed Anal 33: 411-421.
25. Sastry CSP et al. (1997) Spectrophotometric methods for the determination of omeprazole in bulk form and pharmaceutical formulations. Talanta 44: 1211-1217.
26. +)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 2. The reaction cascade induced by treatment with acids. Formation of 5H-pyrido[′,2′:4,5][1, 2,4]thiadiazono-[2,3-a]benzimidazol-13-ium salts and their reaction with thiols. J Org Chem 52: 4582-4592.
27. Storpirtis S, Rodrigues D (1998) In vitro evaluation of dissolution properties and degradation products of omeprazole in enteric-coated pellets. Drug Dev Ind Pharm 24: 1101-1107.
28. Tabata T et al. (1994) Manufacturing method of stable enteric granules of a new antiulcer drug (lansoprazole). Drug Dev Ind Pharm 20: 1661-1672.
29. Tokumura T, Machida Y (2001) UV absorption should not be applied for determining amoxycillin in acidic dissolution test medium. Int J Pharm 228: 1-4.
30. USP (2004) edition 27.
31. Wahbi A-AM et al. (2002) Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations. J Pharm Biomed Anal 30: 1133-1142.